Accelerated Bioorthogonal Conjugation: a Practical Method for the Ligation of Diverse Functional Molecules to a Polyvalent Virus Scaffold
Overview
Affiliations
Covalent bond formation to proteins is made difficult by their multiple unprotected functional groups and normally low concentrations. A water-soluble sulfonated bathophenanthroline ligand (2) was used to promote a highly efficient Cu(I)-mediated azide-alkyne cycloaddition (CuAAC) reaction for the chemoselective attachment of biologically relevant molecules to cowpea mosaic virus (CPMV). The ligated substrates included complex sugars, peptides, poly(ethylene oxide) polymers, and the iron carrier protein transferrin, with routine success even for cases that were previously resistant to azide-alkyne coupling using the conventional ligand tris(triazolyl)amine (1). The use of 4-6 equiv of substrate was sufficient to achieve loadings of 60-115 molecules/virion in yields of 60-85%. Although it is sensitive to oxygen, the reliably efficient performance of the Cu.2 system makes it a useful tool for demanding bioconjugation applications.
Lamontagne F, Khatri V, St-Louis P, Bourgault S, Archambault D Vaccines (Basel). 2022; 10(11).
PMID: 36423016 PMC: 9696568. DOI: 10.3390/vaccines10111920.
Self-assembled Viral Nanoparticles as Targeted Anticancer Vehicles.
Wu Y, Li J, Shin H Biotechnol Bioprocess Eng. 2021; 26(1):25-38.
PMID: 33584104 PMC: 7872722. DOI: 10.1007/s12257-020-0383-0.
Rapid Assembly and Screening of Multivalent Immune Cell-Redirecting Therapies for Leukemia.
Do P, Perdue L, Chyong A, Hunter R, Dougan J, Henry C ACS Comb Sci. 2020; 22(10):533-541.
PMID: 32786324 PMC: 8496977. DOI: 10.1021/acscombsci.0c00081.
[F]FET-βAG-TOCA: The Design, Evaluation and Clinical Translation of a Fluorinated Octreotide.
Allott L, Dubash S, Aboagye E Cancers (Basel). 2020; 12(4).
PMID: 32252406 PMC: 7226534. DOI: 10.3390/cancers12040865.
Design, display and immunogenicity of HIV1 gp120 fragment immunogens on virus-like particles.
Purwar M, Pokorski J, Singh P, Bhattacharyya S, Arendt H, DeStefano J Vaccine. 2018; 36(42):6345-6353.
PMID: 30220462 PMC: 6364316. DOI: 10.1016/j.vaccine.2018.07.032.